Cytochrome P450 2B1 has been subjected to directed evolution to investigate the role of amino acid residues outside of the active site and to engineer novel, more active P450 catalysts. A high throughput screening system was developed to measure H 2 O 2 -supported oxidation of the marker fluorogenic substrate 7-ethoxy-4-trifluoromethylcoumarin (7-EFC). Random mutagenesis by error-prone polymerase chain reaction and activity screening were optimized using the L209A mutant of P450 2B1 in an N-terminally modified construct with a C-terminal His tag (P450 2B1dH). Two rounds of mutagenesis and screening and one subcloning step yielded the P450 2B1 quadruple mutant V183L/F202L/L209A/ S334P, which demonstrated a 6-fold higher k cat than L209A. Further random or site-directed mutagenesis did not improve the activity. When assayed in an NADPH-supported reconstituted system, V183L/L209A demonstrated lower 7-EFC oxidation than L209A. Therefore, F202L/L209A/S334P was generated, which showed a 2.5-fold higher k cat /K m for NADPH-dependent 7-EFC oxidation than L209A. F202L/L209A/S334P also showed enhanced catalytic efficiency with 7-benzyloxyresorufin, benzphetamine, and testosterone, and a 10-fold increase in stereoselectivity for testosterone 16␣-versus 16␤-hydroxylation compared with 2B1dH. Enhanced catalytic efficiency of F202L/L209A/S334P was also retained in the full-length P450 2B1 background with 7-EFC and testosterone as substrates. Finally, the individual mutants were tested for metabolism of the anti-cancer prodrugs cyclophosphamide and ifosfamide. Several of the mutants showed increased metabolism via the therapeutically beneficial 4-hydroxylation pathway, with L209A/S334P showing 2.8-fold enhancement of k cat /K m with cyclophosphamide and V183L/L209A showing 3.5-fold enhancement with ifosfamide. Directed evolution can thus be used to enhance P450 2B1 catalytic efficiency across a panel of substrates and to identify functionally important residues distant from the active site.
Advances in x-ray crystallography, homology modeling, and site-directed mutagenesis have yielded crucial insights into the structural basis of cytochrome P450 catalytic efficiency, differential substrate specificity, stereo-and regioselectivity, and cooperativity (1) (2) (3) (4) (5) (6) (7) (8) (9) . These studies have revealed that substrate binding and oxidation are influenced not only by active site residues but also by residues outside of the active site that play a significant role in initial substrate recognition, substrate access, and redox partner binding (3, 4, 8, 9) .
P450 enzymes of the 2B sub-family are among the best studied from the standpoint of structure-function relationships. These enzymes metabolize many xenobiotics, including the anti-cancer drugs cyclophosphamide (CPA) 1 and ifosfamide (IFA) and environmental contaminants such as polychlorinated biphenyls (1, 10 -12) . Comparison of active site residues among P450 2B enzymes within and across species has led to several successful efforts to enhance and/or re-engineer their activities (2, 10, (13) (14) (15) . However, the extension of these studies to identify functionally important non-active site residues is more problematic. One attractive approach is directed evolution, which has been successfully applied to the design of industrial biocatalysts for enhanced catalytic efficiency, stability, and versatility and for examining the molecular basis of enzyme functions (16 -21) . Recent studies with the bacterial enzyme P450BM3 have illustrated the potential of directed evolution for engineering new and more efficient P450s showing enhanced hydroxylation of unnatural alkane substrates up to 100-fold. The resulting mutant has 10 of the 11 substitutions outside of the active site (22) (23) (24) . Moreover, although the P450BM3 mutant with enhanced activity was selected using one specific substrate, it also showed improved activity with other substrates. Xenobiotic-metabolizing mammalian cytochromes P450, with their generally broader substrate specificity than bacterial P450s, offer the possibility of even greater applications in industrial synthesis, medicine, and bioremediation. Recently, directed evolution of mammalian P450 1A2 in two independent studies yielded mutants with 5-and 10-fold enhanced catalytic efficiency with 7-methoxyresorufin and 2-amino-3,5-dimethylimidazo [4,5-f] quinoline, respectively (25, 26) . The mutations in both cases were outside of the active site.
The present study tests the hypothesis that directed evolution can be used to enhance the activity of P450 2B1 while maintaining versatility. First, we established a sensitive and direct high throughput screening method for a highly expressed truncated form of P450 2B1 using H 2 O 2 -supported oxidation of the marker fluorogenic substrate 7-ethoxy-4-trif-luoromethylcoumarin (7-EFC) followed by optimization of random mutagenesis using error-prone PCR. Mutants with enhanced catalytic activity were then tested with 7-EFC and five other P450 2B1 substrates in a standard reconstituted system using NADPH. The results suggest several residues that may be targeted for mutagenesis to enhance activities toward compounds of medicinal and environmental interest.
EXPERIMENTAL PROCEDURES
Materials-7-EFC and 7-BR were purchased from Molecular Probes, Inc. (Eugene, OR). Polymyxin B sulfate, CPA, and NADPH were bought from Sigma. [4- 14 C]Testosterone was obtained from Amersham Biosciences. 4-Hydroperoxy-CPA was obtained from ASTA Pharma (Beilefeld, Germany). IFA was obtained from the Drug Synthesis and Chemistry Branch of the NCI, National Institutes of Health. Recombinant NADPH-cytochrome P450 reductase (CPR) and cytochrome b 5 (b 5 ) from rat liver were prepared as described previously (27) . Oligonucleotide primers for PCR were either obtained from The University of Texas Medical Branch, (UTMB), Molecular Biology Core Laboratory (Galveston, TX) or from Sigma Genosys (Woodlands, TX). Error-prone PCR and ligation kits were obtained from Roche Applied Science, restriction enzymes from Invitrogen, and the GeneClean kit from BIO 101, Inc. (Vista, CA). Quick-change XL site-directed mutagenesis kit was obtained from Stratagene (La Jolla, CA). Nickel-nitrilotriacetic acid affinity resin was purchased from Qiagen (Valencia, CA). All other chemicals were of the highest grade available and were obtained from standard commercial sources.
Random Mutagenesis by Error-prone PCR and Construction of Mutant Libraries-The method used is a modification of standard PCR methods, designed to alter and enhance the natural error rate of the polymerase, and was essentially performed as described previously for P450BM3 (28) . Initially, error-prone PCR, ligation, and transformation were standardized for P450 2B1dH L209A to obtain Ͼ1000 clones per PCR reaction by selecting suitable forward and reverse primers, restriction sites, ligation conditions, and transformation procedures. Subsequently, error-prone PCR was standardized to ensure a mutation rate of 1-2 bp per P450 cDNA essentially as described previously (28) . This was accomplished by varying the concentrations of nucleotides, especially dCTP and dTTP, and the concentrations of MnCl 2 to give mutation frequencies from 0.11 to 2% (1-20 nucleotides per 1 kb) (28) . Finally, libraries were generated using the various conditions, and the number of mutations per kb was estimated based upon an activity screen as described previously (29) followed by sequencing of the desired mutants.
In the final conditions, the forward and reverse primers were as follows: 5Ј-CAC AGG AAA CAG ACC ATG GCT CCC AGT ATC-3Ј (forward) and 5Ј-CGG ATA TCA ATG GTG GTG ATG CCG AGC TGA GAA-3Ј (reverse). The restriction sites used were PstI and EcoRV. PCR reactions using an error-prone PCR kit included 25 mM MgCl 2 , 10 mM dCTP, 10 mM dTTP, and 2 mM each of dATP and dGTP. The overnight ligation kit was used to obtain Ͼ1000 transformants per ligation reaction using ϳ20% of the PCR products.
The P450 2B1dH mutant F202L/L209A/S334P was generated by quick change site-directed mutagenesis using V183L/F202L/L209A/ S334P as template and 5Ј-TGC TCC ATT GTG TTT GGA GAG-3Ј and 5Ј-CTC TCC AAA CAC AAT GGA-3Ј as forward and reverse primers, respectively. Similarly, F202L and F202L/L209A were generated by site-directed mutagenesis using 2B1dH and L209A as templates, respectively, and 5Ј-CTG TTG GAG CTG TTG TAC CGG ACC TTT-3Ј and 5Ј-AAA GGT CCG GTA CAA CAG CTC CAA CAG-3Ј as forward and reverse primers, respectively. Nucleotides presented in bold represent the site of mutation.
Screening and Selection of P450 2B1dH L209A Random MutantsScreening and selection of 2B1dH L209A random mutants were essentially done as described previously for P450BM3 with minor modifications (30) . Liquid handling was performed using a multichannel robot Biomek 2000 (Beckman, Fullerton, CA). In brief, transformed Escherichia coli (DH5␣) was grown in a 300-l, V-shaped 96-well microplate containing 150 l of LB media for 18 -20 h at 30°C on a microplate shaker. Next, 20 l of the LB-grown cells were inoculated into a 300-l, V-shaped 96-well microplate containing 180 l of TB medium and grown for ϳ3 h until cell density reached A 600 ϭ 1-1.5. ␦-Aminolevulinic acid and isopropyl 1-thio-␤-D-galactopyranoside were then added to the cells to final concentrations of 80 and 240 g/ml, respectively. The cells were then grown for 72 h at 30°C on a microplate shaker. Cells were then harvested by centrifugation at 5000 ϫ g for 10 min using an Allegra 25R microplate centrifuge (Beckman). The supernatant was removed by decanting, and the pellet was dried. The cells were resuspended in 150 l of 0.1 M Hepes buffer, pH 7.4, in the presence of 0.5 mg/ml lysozyme.
Next, 50 l of the substrate mixture (300 M 7-EFC containing 4% methanol and 20 units/well polymyxin B sulfate) was incubated with 40 l of whole cells for 5 min at room temperature. The background intensity was recorded at ex ϭ 405 nm and em ϭ 510 nm using a fluorescence microplate reader (Ascent Fluoroscan, Ramsey, MN). The reaction was initiated by the addition of 10 l of H 2 O 2 (10 mM final), and the formation of product was recorded at 2.5 min. Mutants with Ն2-fold higher activity than the average wild-type activity were sequenced at the UTMB Protein Chemistry Laboratory and were further characterized as described below.
Expression and Purification of Wild-type and Engineered EnzymesP450s 2B1 and 2B1dH and their mutants were expressed as His-tagged proteins in E. coli TOPP3 and purified using a Ni-affinity column as described previously (31) . Protein concentrations were determined using the Bradford protein assay kit (Bio-Rad). The specific contents were between 8 and 15 nmol of P450 per milligram of protein. Upon purification, the yield, purity, and stability of the mutant proteins were either similar to or higher than the respective wild-type enzymes (2B1 and 2B1dH).
-supported enzyme activities were assayed as described previously with slight modifications (32) . Substrate mixtures were prepared in 100 mM Hepes buffer, pH 7.4, with 2% as the final concentration of methanol (100 l/well of a 96-well microplate). The substrate mixture was preincubated with 50 pmol of purified P450 enzyme at room temperature for 5 min. Reactions were initiated by the addition of H 2 O 2 to 10 mM. After 5 min of incubation, the reactions were stopped by adding 340 units (50 l) of catalase. Subsequently, 50 l of 100 mM Hepes buffer, pH 7.4, was added prior to recording the fluorescence intensity at ex ϭ 405 nm and em ϭ 510 nm using an Accent fluorescence plate reader. NADPH-dependent Enzyme Assays-7-EFC and 7-BR oxidation were assayed using a fluorescence method (4) . Benzphetamine N-demethylation was measured using a colorimetric method (9) . Testosterone hydroxylation was assayed by TLC using radiolabeled substrate (2) . The reconstitution of P450 2B1 and 2B1dH with CPR and b 5 in the NADPH system was carried out at ratios of 1:4:2 (31) and included 10 g of dilauroylphosphatidylcholine/100-l reaction volume in the P450 2B1 sample only. The reconstitution system for assaying CPA and IFA metabolism included P450 and purified rat liver CPR in a 1:4 molar ratio (5 pmol of P450/0.1 ml of 0.1 M KP i buffer, pH 7.4, containing 0.1 mM EDTA) and was devoid of lipid and b 5 . CPA and IFA metabolism were assayed by high-performance liquid chromatography as described (10) . Steady-state kinetic parameters for 7-EFC, testosterone, 7-BR, and benzphetamine were determined by regression analysis using Sigma Plot (Jandel, San Rafel, CA). The K m value was determined using the Michaelis-Menten equation, whereas the S 50 and n values were determined using the Hill equation. Kinetic analysis of CPA and IFA metabolism was carried out using Enzyme Kinetics version 0.44 software (Trinity Software, Inc.).
P450 2B1 Model-The 2B1 model was made essentially as described (2) . In brief, the initial molecular model was constructed using the Insight II software package (Homology, Discover_3, Biopolymer and Builder from Molecular Simulations, Inc., San Diego, CA). The model was constructed based on the crystal structure of a ligand-bound P450 2B4 complex (PDB entry 1SUO) (8) . The sequence of rat 2B1 was obtained from SwissProt (accession number P00176). The coordinates of the conserved residues were assigned based on the corresponding residues of the 2B4 complex by Homology/Insight II. The heme group was copied from 2B4 into the 2B1 model.
RESULTS

Directed Evolution of P450 2B1dH-
The most critical step of directed evolution is to find a simple, economical and high throughput activity screen. A facile assay method was sought to circumvent steps involving CPR and b 5 by using an alternate oxygen donor such as H 2 O 2 , as reported previously for bacterial P450eryF (22) . To maximize heterologous expression and subsequent purification, an N-terminally modified construct of P450 2B1 with a C-terminal His tag was used (P450 2B1dH). Several known substrates of 2B1dH (derivatives of quinoline and coumarin) were tested using H 2 O 2 and cumene hydroperoxide as oxygen donors. The combination of 7-EFC with H 2 O 2 was found to give the highest signal-to-noise ratio and good reproducibility (data not shown). To further optimize the method, potassium phosphate, Tris-HCl, and Hepes buffer were tested in the absence and presence of MgCl 2 ; Hepes buffer without MgCl 2 gave maximal activity. H 2 O 2 -supported 7-EFC O-deethylation proceeded at ϳ5% the rate of the NADPHsupported activity under optimal conditions with purified 2B1dH (data not shown) (4). The H 2 O 2 -supported activity correlated well with the activity determined using NADPH across a panel of more than 10 active site mutants (Refs. 4 and 9 and data not shown).
2B1dH L209A had 10-fold higher H 2 O 2 -supported 7-EFC deethylation activity than 2B1dH and was therefore used as the starting template for directed evolution. In adapting the assay to bacterial cells grown on microtiter plates, a number of difficulties were encountered, including high background, low activity, and variable expression. Improvements were obtained by eliminating imidazole from the TB culture medium, using whole cells in place of cell extracts, and using 300 l of Vshaped 96-well microplates instead of 1-ml deep well microplates. A representative assay of multiple colonies of 2B1dH L209A indicated ϳ80% colony-to-colony variation in activity (Fig. 1, open squares) compared with the average 2B1dH L209A colony (Fig. 1, horizontal line) . These data suggested that random clones having Ն2-fold higher activity than 2B1dH L209A would correspond to mutants with enhanced catalytic activity.
Identification of 2B1dH Mutant V183L/F202L/L209A/S334P with a 6-fold Increased k cat -Representative data from an initial screen of several hundred random clones derived by directed evolution of 2B1dH L209A are shown in Fig. 1 , with the clones graphed in order of decreasing activity (closed squares). Two of the clones (1H3 and 1C10) showed activity of Ն2-fold higher than the average of 2B1dH L209A, and higher than any single 2B1dH L209A colony. DNA sequencing revealed a single new mutation in each case, S334P (clone 1H3) and V183L (clone 1C10). V183L/L209A and L209A/S334P were expressed in large scale culture and purified. Both showed similar expression levels as 2B1dH, as reported earlier for L209A (4) . L209A/ S334P and V183L/L209A had 50 -58% higher k cat values than L209A (Table I) . In an effort to enhance the activity further, the triple mutant V183L/L209A/S334P was prepared. This mutant displayed ϳ2-fold higher k cat than L209A (Table I) .
Directed evolution using V183L/L209A/S334P as the template yielded V183L/F202L/L209A/S334P. This quadruple mutant had a 3-fold higher k cat than V183L/L209A/S334P and 6-fold higher k cat than L209A, along with an increased S 50 and an n value of 1.6 (Table I) . A third round of mutagenesis and screening did not yield any colonies with a further Ն2-fold increase in activity. Five of the most active clones were sequenced, which identified only one clone with an additional mutation, E322K. Purified V183L/F202L/L209A/E322K/S334P showed no further enhancement of k cat , suggesting that random mutagenesis was approaching saturation for enhanced 7-EFC O-deethylation (data not shown). We therefore sought a rational mutagenesis approach in an effort to achieve higher activity. Of several 2B1dH active site mutants (V103A, V103I, I114A, L208A, L220A, S221P, I290A, and I290F) available from earlier studies (2, 4, 9) that showed higher NADPH-dependent activity, I290F showed 3-fold higher H 2 O 2 -dependent activity than 2B1dH (data not shown). However, V183L/F202L/ L209A/I290F/S334P showed no increase in k cat beyond V183L/ F202L/L209A/S334P (data not shown), again suggesting saturation of activity along this particular directed evolution pathway.
F202L/L209A/S334P Demonstrates the Highest Catalytic Efficiency of NADPH-dependent 7-EFC O-Deethylation-Subse-
quently, the 2B1dH mutants were assayed in a standard reconstituted system using NADPH. Compared with 2B1dH L209A, L209A/S334P had 37% higher k cat /K m , whereas V183L/ L209A had a ϳ20% lower k cat /K m (Table II) . Adding F202L to V183L/L209A/S334P increased the k cat /K m for 7-EFC ϳ2-fold, whereas incorporation of E322K did not enhance the activity further (Table II , data not shown). Interestingly, V183L/F202L/ L209A/S334P did not show cooperativity in the NADPH-dependent system (data not shown). In contrast to the H 2 O 2 -supported activity, incorporation of I290F into V183L/F202L/ L209A/S334P decreased the k cat /K m by ϳ25% in the NADPHdependent system (data not shown). Because V183L decreased NADPH-supported activity, this mutation was removed from V183L/F202L/L209A/S334P. The resulting triple mutant F202L/L209A/S334P showed the highest k cat /K m (ϳ2.5-fold higher than L209A) of all samples tested (Table II) . As expected, F202L/L209A/S334P showed slightly lower activity than V183L/F202L/L209A/S334P in the H 2 O 2 -supported system (data not shown).
F202L/L209A/S334P Exhibits Enhanced Oxidation of Several Other Substrates-
The 2B1dH random mutants were tested with 7-BR, benzphetamine, and testosterone to investigate whether the enhanced NADPH-dependent activity was retained across structurally diverse substrates (Fig. 2) . Testosterone 16␣-hydroxylation paralleled NADPH-supported 7-EFC oxidation across the panel of mutants. As expected, F202L/ L209A/S334P showed the highest activity (Fig. 2) , along with Ͼ10-fold increase in stereoselectivity for testosterone 16␣-over 16␤-hydroxylation. With 7-BR as substrate, the relative activities of the mutants were somewhat different from 7-EFC and testosterone, and V183L/F202L/L209A/S334P showed higher activity than F202L/L209A/S334P (Fig. 2) . The relative activities of the mutants with benzphetamine were very different from the other substrates. Although most of the mutations had little or no effect on benzphetamine metabolism, F202L/L209A/ S334P showed ϳ2-fold higher activity than 2B1dH or 2B1dH L209A (Fig. 2) .
Steady-state kinetic analysis of the oxidation of testosterone, 7-BR, and benzphetamine was performed with 2B1dH and three of the mutants (Table III) . Although V183L/F202L/ L209A/S334P showed the highest activity at saturating 7-BR concentration, F202L/L209A/S334P showed the highest k cat /K m (ϳ3-fold higher than L209A) due in part to a ϳ2-fold decrease in K m value. Relative to L209A, F202L/L209A/S334P showed a ϳ4-fold improved k cat /K m with benzphetamine and 1.7-fold improved k cat /K m for testosterone 16␣-hydroxylation. Thus, F202L/L209A/S334P showed enhanced catalytic efficiency with four structurally distinct substrates.
F202L/L209A/S334P Demonstrates Enhanced Catalytic Activity When Incorporated into Full-length 2B1-The next step was to test whether the enhanced activity of F202L/L209A/ S334P seen in the 2B1dH (N-terminal deleted) background was manifest when introduced into full-length 2B1. Results of kinetic analysis of 2B1 F202L/L209A/S334P with 7-EFC, 7-BR, benzphetamine, and testosterone are shown in Table IV . F202L/L209A/S334P showed a k cat /K m value that was Ͼ20-fold higher than full-length 2B1 for testosterone 16␣-hydroxylation.
The stereoselectivity for testosterone 16␣-hydroxylation was also increased by 10-fold. F202L/L209A/S334P catalyzed testosterone 16␣-hydroxylation with a k cat (150 min Ϫ1 ) that is among the highest reported for any mammalian cytochrome P450 in an NADPH-supported reaction. F202L/L209A/S334P did not show enhanced catalytic efficiency for 7-BR or benzphetamine oxidation, perhaps reflecting the different phospholipid dependences of full-length versus truncated P450 2B1 and the proximity of residues 202 and 209 to a proposed secondary lipid binding site (33) .
Role of F202L in Substrate Metabolism-Analysis of the above described mutants suggested that F202L may contribute significantly to the enhanced enzyme activity seen with several substrates. Therefore, kinetic analysis was performed with F202L and F202L/L209A in the 2B1dH background (Table V) . Surprisingly, F202L showed decreased activity with 7-EFC in the H 2 O 2 -supported reaction compared with 2B1dH. In addition, F202L showed a decreased k cat for the oxidation of 7-EFC and 7-BR, and for testosterone 16␣-hydroxylation compared with 2B1dH (Tables II and III versus Table V) . Compared with L209A, F202L/L209A showed enhancement in the k cat by 2.5-fold for 7-EFC deethylation in the H 2 O 2 -supported reaction (Table I versus V). In addition, compared with L209A, F202L/ L209A showed 1.5-to 1.9-fold enhanced k cat /K m for the oxidation of 7-EFC and 7-BR, and for testosterone 16␣-hydroxylation in the standard reconstituted system (Tables II and III versus  Table V) . F202L/L209A also showed enhanced stereoselectivity by Ͼ14-fold for testosterone 16␣-versus 16␤-hydroxylation compared with 2B1dH (data not shown).
2B1dH Mutants L209A/S334P and V183L/L209A, Respectively, Show Enhanced Catalytic Efficiency for CPA and IFA 4-Hydroxylation-Finally, selected P450 2B1 mutants were tested for improved catalytic properties toward the anti-cancer prodrugs CPA and IFA, as judged by decreases in K m , increases in k cat for 4-hydroxylation (drug activation), or decreases in k cat for N-dechloroethylation, an undesirable toxic side-reaction. Initial studies revealed that 2B1dH showed a 3-fold decrease in K m for both CPA and IFA (Fig. 3 ) compared with full-length 2B1, without a significant change in k cat (10) . Moreover, each of the 2B1dH mutants showed a 2-to 3-fold further decrease in K m for CPA compared with 2B1dH (Fig. 3) , as well as 3-to 7-fold decreases in k cat for CPA N-dechloroethylation (data not shown). However, only L209A/S334P showed an enhanced k cat for CPA 4-hydroxylation. The catalytic efficiency of L209A/ S334P for CPA 4-hydroxylation was improved 2.8-fold over 2B1dH and represents the highest value observed to date (220 min Ϫ1 mM Ϫ1 ) for this reaction by a mammalian P450. With IFA as substrate, k cat and k cat /K m for the 4-hydroxylation reaction were the highest for V183L/L209A (Fig. 3) . F202L/ L209A/S334P also exhibited an elevated k cat compared with 2B1dH, but the K m of that triple mutant was also elevated, such that there was no overall improvement in catalytic efficiency. The other 2B1dH mutants had k cat values similar to L209A and slightly increased over 2B1dH. The overall improvement in the catalytic efficiency of V183L/L209A and V183L/F202L/L209A/S334P was ϳ2.5-to 3-fold over 2B1dH. V183L/L209A and V183L/F202L/L209A/S334P are the most efficient among the 2B1 mutant enzymes for IFA 4-hydroxylation (k cat /K m ϳ50 -70 min Ϫ1 , mM Ϫ1 ). Finally, all the mutants showed significantly decreased IFA N-dechloroethylation (61% metabolism of IFA via the N-dechloroethylation pathway for 2B1dH versus 41-47% IFA N-dechloroethylation by each of the mutants; data not shown).
DISCUSSION
As a complement to extensive prior site-directed mutagenesis, homology modeling, and x-ray crystallographic studies, we developed a directed evolution approach for mammalian xenobiotic-metabolizing cytochromes P450 2B. A major goal was to identify non-active site substitutions that might enhance activity across a panel of structurally diverse substrates, as seen earlier in bacterial P450BM3, in which random mutagenesis yielded 10 of the 11 beneficial mutations in non-active site regions (23) . Development of this approach with P450 2B1 was greatly facilitated by the availability of 2B1dH L209A, which shows 10-fold higher heterologous expression and a 2-fold 
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Results are the representative of at least two independent determinations. The variation between the experiments is Յ10%. Results are the representative of at least two independent determinations. The variation between the experiments is Յ10%. higher k cat for 7-EFC O-deethylase activity than full-length 2B1 (4, 31) . Two rounds of directed evolution and one subcloning step yielded 2B1dH V183L/F202L/L209A/S334P, which exhibited a 6-fold enhanced k cat for 7-EFC metabolism in an H 2 O 2 -supported reaction. Elimination of the V183L mutation, which proved deleterious for 7-EFC metabolism supported by NADPH in a standard reconstituted system, yielded a triple mutant, F202L/L209A/S334P, which displayed 3-to 4-fold enhanced catalytic efficiency toward 7-BR, benzphetamine, and testosterone. This triple mutant also retained enhanced catalytic efficiency with 7-EFC and testosterone in the full-length 2B1 background. One advantage of directed evolution from the standpoint of generating novel catalysts for biomedical or bioengineering applications is that only mutants with good expression levels and stability are isolated in the whole cell screens. In contrast, mutagenesis targeted to the active site often yields mutants with decreased expression and/or stability, especially when multiple substitutions are combined (2) .
Although, 2B1dH V183L/F202L/L209A/S334P and F202L/ L209A/S334P exhibited enhanced catalytic efficiency with several substrates, some interesting differences in function were also observed, including differences between H 2 O 2 -and NADPHdependent 7-EFC O-deethylation, NADPH-dependent oxidation of one substrate versus another substrate (e.g. IFA versus CPA), and catalytic activity of 2B1dH versus full-length 2B1. Clearly these differences reflect the location of the mutated residues in the three-dimensional structure of the protein. Although no x-ray crystal structure of P450 2B1 is available, the recently solved structure of an inhibitor-bound form of P450 2B4 (8) provides the best possible template for homology modeling (Fig. 4) . Two of the three 2B1 mutations (V183L and S334P) map to regions of the protein distant from the active site. Residue 183 is located in the E-helix (near SRS 2) and has not previously been implicated in P450 function. More recently, random mutagenesis of P450 1A2 generated a Val 193 3 Met mutation, which may contribute to enhanced oxidation of 7-methoxyresorufin (26) . Residue 193 is presumed to be located in the E-helix, suggesting an important functional role of this region. Although, V183L/L209A did not show enhanced activity in the NADPH-dependent system with most of the substrates tested, it showed enhanced catalytic efficiency and increased regioselectivity for IFA 4-hydroxylation. The enhanced H 2 O 2 -dependent but diminished NADPH-dependent 7-EFC O-deethylase activity of V183L/L209A relative to L209A is also intriguing and suggests impairment of the interaction with redox partners (CPR and/or b 5 ), leading to a decrease in hydroperoxy complex formation. The other important residue identified here, Ser 334 , is located in the J-JЈ loop (between substrate recognition sites 5 and 6), and also has not been implicated previously in P450 function. Interestingly, introduction of S334P enhanced catalytic efficiency with all the substrates tested in the NADPH-dependent system. The presence of Pro at the same position in P450 2B11 may contribute to its high catalytic efficiency and regioselectivity for CPA 4-hydroxylation (cf., Ref. 10). Analysis of long range effects of residues 183 and 334 as described by Hilser and colleagues may shed light on some of these observations (34, 35) .
Although, Phe 202 3 Leu is deleterious for 2B1 activity with several substrates, the addition of F202L to L209A or to V183L/ L209A/S334P enhanced catalytic activity. In addition, inclusion of F202L increased the stereoselectivity of testosterone 16␣-hydroxylation (Fig. 2) , as was observed for L209A (4) . Based on earlier mutagenesis work, this region of the protein is important for substrate binding, substrate specificity, and stereo-and regioselectivity in P450 2B and P450 2C enzymes (2, 4, 33) . Amino acids 201-210 have been proposed to form a secondary lipid binding site in P450 2C5 and 2C3 (33) . In particular, residues 201, 202, and 205 contribute to the differences in catalytic activity between P450 2C5 and 2C3 and in the lipid dependence of the two enzymes. Therefore, it is likely that due to different lipid requirements, the Phe 202 3 Leu mutation leads to differences in activity between truncated and fulllength 2B1 F202L/L209A/S334P for 7-BR and benzphetamine oxidation.
Based on the 4-(4-chlorophenyl)imidazole-bound 2B4 struc- ture (8) , and a 2B1 model docked with testosterone (data not shown), Phe 202 is outside of the active site (distance from the substrate Ͼ 8.0 Å). Residue Leu 209 in 2B1 and 2B4 is Յ5.0 Å from the substrate in the active site. Phe 202 and Leu 209 may also be critically important residues for making the 15-Å open cleft between helices F and G, as seen in the substrate-free P450 2B4 structure. This open cleft has been proposed to control the entry of a diverse array of substrates (3, 8) . Based on the prediction from the P450 2B4 crystal structure and our overall data it appears that helix F and the FЈ region are critical for enzyme activity, substrate specificity, stereo-and regioselectivity, and enzyme cooperativity. Therefore, a more targeted mutagenesis approach in this region may be very fruitful.
Our observations with specific mutants are interesting from the standpoint of developing an improved P450 2B enzyme for use in activating the anti-cancer prodrugs CPA and IFA in the context of gene therapy treatment for cancer (36, 37) . At present, P450 2B11 is the most efficient catalyst of CPA and IFA activation, which proceeds via 4-hydroxylation. Earlier efforts to improve the catalytic efficiency of P450 2B1 with CPA and IFA revealed that 2B1 mutants I114V and I114V/V363I have a ϳ2-fold enhanced k cat /K m for CPA and IFA 4-hydroxylation, respectively (10) . These results prompted the investigation of 2B11, which has Val 114 and Leu 363 . Interestingly, 2B1dH V183L/L209A and L209A/S334P, generated by directed evolution, not only showed ϳ3-fold enhanced catalytic efficiency for activation of the prodrug substrates IFA and CPA, respectively, but also increased regioselectivity for metabolism via the 4-hydroxylation pathway. Given the ϳ2-fold decrease in K m for CPA 4-hydroxylation seen with all of the L209A-containing 2B1 mutants examined (Fig. 3) , introduction of the Leu 209 3 Ala substitution into 2B11 may lead to a corresponding decrease in K m and an increase in catalytic efficiency and/or regioselectivity for CPA 4-hydroxylation.
In summary, our results demonstrate that directed evolution of P450 2B1 can be used to identify critical amino acid substitutions and combinations of substitutions outside of the active side that are unlikely to be identified or predicted from x-ray crystal structures. The mutants described here showed high expression and stability along with enhanced catalytic efficiency toward multiple substrates. This study should facilitate further design of P450s for synthetic, medical, and environmental applications. This approach may also be utilized for random mutagenesis of P450 2B1 in the F-G region, and may be applied to other mammalian P450s of medical or industrial importance.
